Ac Immune Sa
Clinical trials sponsored by Ac Immune Sa, explained in plain language.
-
Experimental Alzheimer's vaccine aims to clear brain plaques
Disease control Recruiting nowThis study tests an experimental vaccine called ACI-24.060 in people with early Alzheimer's and non-demented adults with Down syndrome. The vaccine is designed to help the immune system clear amyloid plaques from the brain, which are linked to Alzheimer's. Researchers will check …
Phase: PHASE1, PHASE2 • Sponsor: AC Immune SA • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New PET tracer aims to spot Parkinson's protein in the brain
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [18F]ACI-15916, designed to detect clumps of α-synuclein protein in the brain using PET scans. These protein deposits are linked to Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. The trial …
Phase: EARLY_PHASE1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
New brain drug ACI-19764 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage trial is testing a new drug called ACI-19764 in 78 healthy adults to see if it is safe and how the body handles it. The drug targets a protein in the brain linked to inflammation. Participants will receive either the drug or a placebo, and researchers will monito…
Phase: PHASE1 • Sponsor: AC Immune SA • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC